Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2003
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037889A1 Compounds and method for the treatment of overactive bladder
05/08/2003WO2003037864A1 Indole compound and medicinal use thereof
05/08/2003WO2003037432A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
05/08/2003WO2003037400A2 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037381A1 Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility
05/08/2003WO2003037377A1 Preventives/remedies for proliferative organ diseases, chronic arthritic diseases, hypertrophic scar or keloid
05/08/2003WO2003037375A1 Cytokine-inducing material and cytokine-inducing instrument
05/08/2003WO2003037373A1 Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037360A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037348A1 Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of dysmenorrhea and menorrhagia
05/08/2003WO2003037344A1 Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
05/08/2003WO2003037341A1 Method for the treatment of overactive bladder
05/08/2003WO2003037340A1 Inhibitors of abc drug transporters in cancer cells
05/08/2003WO2003037334A1 Method for treating or preventing symptoms of hormonal variation including hot flashes
05/08/2003WO2003037329A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
05/08/2003WO2003037325A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003WO2003037322A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
05/08/2003WO2003037318A1 Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy
05/08/2003WO2003037310A2 Use of inhibitors of the abc drug transporter to increase the activity of anti-microbial agents
05/08/2003WO2003037308A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003WO2003037303A1 Spray drying methods and compositions thereof
05/08/2003WO2003037300A1 Gastric raft composition
05/08/2003WO2003037298A2 Bowel cleansing agent
05/08/2003WO2003037291A1 Cream for treatment of skin injured by the sun
05/08/2003WO2003037286A1 Composition in the form of an emulsion that can be used to treat plantar bromhidrosis and/or hyperhidrosis
05/08/2003WO2003037258A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/08/2003WO2003037257A2 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
05/08/2003WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
05/08/2003WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
05/08/2003WO2003037168A2 Methods and formulations for minimizing spasticity in blood vessel grafts
05/08/2003WO2003037167A2 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
05/08/2003WO2003037166A2 Devices and methods for the restoration of a spinal disc
05/08/2003WO2003037165A2 System and method for the pretreatment of the endplates of an intervertebral disc
05/08/2003WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/08/2003WO2003037080A1 Nonhuman model animal of systemic lupus erythematosus
05/08/2003WO2003037079A1 NONHUMAN MODEL ANIMAL OF Th2-MEDIATED HYPERIMMUNE RESPONSE
05/08/2003WO2003023404A8 A method of diagnosis and treatment and agents useful for same
05/08/2003WO2003022192B1 Eustachian tube stent
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2003000027A3 Blocking peptide for inflammatory cell secretion
05/08/2003WO2002097114A3 Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
05/08/2003WO2002096432A3 Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same
05/08/2003WO2002094377A3 Pharmaceutical preparation comprising physiologically acceptable potassium and magnesium salts and use thereof for the prophylaxis and treatment of qt-interval extension
05/08/2003WO2002090974A3 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
05/08/2003WO2002085414A3 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
05/08/2003WO2002069985A3 Immune response potentiation
05/08/2003WO2002053089B1 Stable skin conditioning compositions containing retinoid boosters
05/08/2003WO2002026223A3 Catecholamine pharmaceutical compositions and methods
05/08/2003WO2002020768A9 Caveolin peptides and their use as therapeutics
05/08/2003WO2002009702A8 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/08/2003US20030088085 MPROT12 polynucleotides and methods thereof
05/08/2003US20030088061 Materials and methods to modulate ligand binding/enzymatic activity of alpha/beta proteins containing an allosteric regulatory site
05/08/2003US20030087964 Method and pharmaceutical composition for the treatment of cancer
05/08/2003US20030087962 Anti-inflammatory, anti-pain and vasoconstrictive arthroscopic surgical irrigation solutions.
05/08/2003US20030087946 Inhibits tumor cell growth
05/08/2003US20030087944 Such as a 1H-indole-3-glyoxylamide.
05/08/2003US20030087941 Administering a dopamine D1, D2, D3, and D4 receptor agonist such as pramipexole or talipexole.
05/08/2003US20030087933 Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
05/08/2003US20030087924 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087912 Aryl oxime-piperazines useful as CCR5 antagonists
05/08/2003US20030087911 Methods and compositions for treating hypertension
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087895 Fused imidazole derivatives as multidrug resistance modulators
05/08/2003US20030087893 Compositions containing alpha-2-adrenergic agonist components
05/08/2003US20030087878 Methods and formulations for minimizing spasticity in blood vessel grafts
05/08/2003US20030087872 Fucosidase 32616 is differentially expressed in tumor and/or angiogenic tissue samples as compared to normal tissue samples
05/08/2003US20030087861 Administering mixture of antibody and drug; cancer sensitivity
05/08/2003US20030087846 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
05/08/2003US20030087845 Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
05/08/2003US20030087839 Combined preparations comprising morpholine anthracyclines and anticancer agent
05/08/2003US20030087830 Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof
05/08/2003US20030087826 Conjugates comprising two active agents
05/08/2003US20030087823 Compositions comprising endotoxin neutralizing protein and derivatives and uses thereof
05/08/2003US20030087821 Using exendrin, or antagonist thereof; appetite control
05/08/2003US20030087814 Synergistic mixture of enzyme inhibitor of aldehyde dehydrogenase and monoamine oxidase
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
05/08/2003US20030087420 Transgenic animals and cells expressing proteins necessary for susceptibility to HIV infection
05/08/2003US20030087408 Protein for use in the treatment of tumors
05/08/2003US20030087375 Sperm specific proteins
05/08/2003US20030087343 Novel SLGP nucleic acid molecules and uses therefor
05/08/2003US20030087339 Alzheimer's disease; Parkinson's disease; rheumatic disorders
05/08/2003US20030087328 Optical probe for use in detecting and measuring translational adjustments to proteins
05/08/2003US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087302 Detection of modulators of advanced glycation end product activity; obtain sample containing advanced glycation end product activity, incubate with peptide monitor adjustment in activity, adjustment in activity indicates modulator
05/08/2003US20030087299 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/08/2003US20030087266 IGs as modifiers of the p53 pathway and methods of use
05/08/2003US20030087252 Novel compositions and methods in cancer associated with altered expression of PRDM11
05/08/2003US20030087249 93870, a human G-protein coupled receptor and uses therefor
05/08/2003US20030087234 Preparation of labeled biopolymers in situ; obtain bacteria, incubate with label and reaction mixture, separate, recover and analyze labeled bacteria
05/08/2003US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering
05/08/2003US20030086980 Method for the suppression of visceral pain by regulating T type calcium channel
05/08/2003US20030086971 For therapy of allergic and/or inflammatory conditions of the skin and airway passages
1 ... 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 ... 1151